Activity Chair:
SriniVas R. Sadda, MD
President and Chief Scientific Officer
Stephen J. Ryan Endowed Chair
Doheny Eye Institute
Professor of Ophthalmology, UCLA
Los Angeles, CA
Faculty:
Brandon G. Busbee, MD
Physician Partner, Tennessee Retina
Nashville, TN
Giovanni Staurenghi, MD
Professor of Ophthalmology
University of Milan
Milan, Italy
Rishi P. Singh, MD
Staff Physician, Cole Eye Institute, Cleveland Clinic
Associate Professor of Ophthalmology
Case Western Reserve University
Medical Director, Clinical Systems Office
Cleveland, OH
Reviewers:
Joseph F. Burke Jr., MD
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP (Recertification review on 11/25/2017)
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Activity Chair and Faculty member reports the following relationship(s) which are accurate at the time of original content release (December 14, 2016):
SriniVas R. Sadda, MD
Consulting Fees: Alcon, Allergan, Carl Zeiss Meditec, Genentech, Novartis, Optos, Roche
Contracted Research: Allergan, Carl Ziess Meditec, Genentech, Optos
Brandon G. Busbee, MD
Royalty: Akorn, Valeant
Consulting Fee: Aerpio, Genentech, Valeant
Ownership Interest: Akorn, Hemera, Promisight
Giovanni Staurenghi, MD
Receipt of Intellectual Property/Patent: Ocular Instruments
Consulting Fees: Alcon, Allergan, Bayer, Boheringer-Ingelheim, Carl Zeiss Meditec, Centervue, Genentech, Heidelberg Engineering, Novartis, Optos, Optovue, Quantel Medical, Roche
Speakers Bureau: Allergan, Bayer, Carl Zeiss Meditec, Centervue, Genentech, Heildelberg Engineering, Novartis, Optovue, Quantel Medical, Roche
Rishi P. Singh, MD
Consulting Fees: Alcon, Genentech, Regeneron, Shire
Contracted Research: Alcon, Genentech, Regeneron
Reviewers report the following relationship(s):
Joseph F. Burke Jr., MD
Speakers Bureau: ThromboGenics
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.